Diabetes Technology

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

By

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

No Fingerstick Necessary: FDA Approves Novel Continuous Glucose Monitoring System for Diabetes

No Fingerstick Necessary: FDA Approves Novel Continuous Glucose Monitoring System for Diabetes

By

New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.

Algorithm Produces Personalized Glucose Forecast for Patients with T2D

Algorithm Produces Personalized Glucose Forecast for Patients with T2D

Machines were used to examine the glycemic impact of various meals to determine a glucose forecast.

NIH Announces Major Artificial Pancreas Clinical Trials

NIH Announces Major Artificial Pancreas Clinical Trials

By

The studies will assess the safety, efficacy, and user-friendliness among other aspects, of multiple artificial pancreas devices.

Continuous Glucose Monitoring Improves HbA1c in T1D

Continuous Glucose Monitoring Improves HbA1c in T1D

By

Patients with type 1 diabetes who used multiple insulin injections daily experienced reductions in HbA1c with continuous glucose monitoring.

FDA Expands Indication for Dexcom G5 Continuous Glucose Monitoring System

FDA Expands Indication for Dexcom G5 Continuous Glucose Monitoring System

By

The FDA's expanded indication for the Dexcom G5 Continuous Glucose Monitoring System allows for replacement of fingerstick glucose testing.

FDA: Continuous Glucose Monitoring Insulin Pump Approved for Pediatric Patients with Diabetes

FDA: Continuous Glucose Monitoring Insulin Pump Approved for Pediatric Patients with Diabetes

By

The system allows patients and their caregivers to access glucose measurements through their pump or through a mobile app.

Contour Next One Glucose Monitoring System Approved by FDA

Contour Next One Glucose Monitoring System Approved by FDA

By

The Contour®Next One Blood Glucose Management System will be available in early 2017.

Implantable Continuous Glucose Monitor Safe, Effective in Diabetes

Implantable Continuous Glucose Monitor Safe, Effective in Diabetes

By

An implantable continuous glucose monitor appears to be a safe and effective alternative to a transcutaneous monitor in diabetes.

The 'Artificial Pancreas' Has Arrived

The 'Artificial Pancreas' Has Arrived

By

FDA approval of the first closed-loop insulin delivery system is exciting for both physicians and patients. What does this mean for the future?

FDA Green-lights First 'Artificial Pancreas' for Type 1 Diabetes

FDA Green-lights First 'Artificial Pancreas' for Type 1 Diabetes

By

Approval was based on a clinical trial that included 123 people with type 1 diabetes who used the MiniMed 670G hybrid closed-loop system for 3 months, after a 2-week period of no use.

Artificial Pancreas Moving Steadily Toward Commercial Approval

Artificial Pancreas Moving Steadily Toward Commercial Approval

By

The FDA is coordinating with investigators, manufacturers, clinicians, and others to bring automated insulin delivery devices to market.

Automated Artificial Pancreas System May Benefit Hospitalized Type 2 Diabetes Patients

Automated Artificial Pancreas System May Benefit Hospitalized Type 2 Diabetes Patients

By

The system was feasible, safe, and effective for managing hyperglycemia in this patient population.

Artificial Pancreas Protocol Considered Safe, Feasible for Young Children With Type 1 Diabetes

Artificial Pancreas Protocol Considered Safe, Feasible for Young Children With Type 1 Diabetes

Artificial pancreas was linked to 3-fold reduction of time-in-hypoglycemia for 5- to 9-year-olds.

Digital Assistant to Artificial Pancreas Improved Glucose Control in Type 1 Diabetes

Digital Assistant to Artificial Pancreas Improved Glucose Control in Type 1 Diabetes

Overnight-only and 24/7 closed-loop control reduced hypoglycemia and increased time in range.

Blood Glucose Meter Accuracy Called Into Question

Blood Glucose Meter Accuracy Called Into Question

The paper raises questions regarding safety for measuring blood glucose, and when blood glucose meters are used in trials.

A Call for Improved Surveillance of Insulin Pump Therapy

A Call for Improved Surveillance of Insulin Pump Therapy

Experts are now calling for a more standardized and transparent approach to identifying and reporting adverse events with insulin pump therapy.

FDA Clears t:flex Insulin Pump for Marketing

FDA Clears t:flex Insulin Pump for Marketing

By

The FDA has cleared the t:flex Insulin Pump, which has the largest capacity available in the U.S., for marketing.

FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System

FDA Approves Animas Vibe Insulin Pump and Continuous Glucose Monitoring System

By

The FDA has approved the Animas Vibe insulin pump and continuous glucose monitoring system for patients with diabetes.

Artificial Pancreas Effective in Unsupervised, At-Home Setting

Artificial Pancreas Effective in Unsupervised, At-Home Setting

By

Type 1 diabetes patients experienced improved glucose control and less hypoglycemia with use of an artificial pancreas vs. sensor-augmented pump therapy.

Roche Launches First Glucose Meter With Insulin Calculator

Roche Launches First Glucose Meter With Insulin Calculator

Roche announced the launch of Accu-Chek Aviva Expert system, the first blood glucose meter with a built-in insulin calculator.

The Artificial Pancreas: Revolutionizing Type 1 Diabetes Care

The Artificial Pancreas: Revolutionizing Type 1 Diabetes Care

Patients with type 1 diabetes may improve glucose control while reducing the frequency of hypoglycemic episodes with the arrival of the artificial pancreas.

Sign Up for Free e-Newsletters